Swine Flu Antibodies
Lab Reagents
Human IgG antibody Laboratories manufactures the swine flu antibodies reagents distributed by Genprice. The Swine Flu Antibodies reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Swine products are available in stock. Specificity: Swine Category: Flu Group: Antibodies
Swine Albumin Antibody |
|||
12004-05011 | AssayPro | 150 ug | EUR 260.4 |
Swine Haptoglobin Antibody |
|||
15771-05011 | AssayPro | 150 ug | EUR 260.4 |
Swine Prothrombin Antibody |
|||
25887-05011 | AssayPro | 150 ug | EUR 260.4 |
Goat Swine IgG |
|||
A21090-01ml | Abbkine | 0.1ml | EUR 92.4 |
Description: A polyclonal antibody for detection of Goat Swine IgG from Swine. This Goat Swine IgG antibody is for WB, IHC-P, ELISA. It is Affinity purified using solid phase Swine IgG (H&L) with finally > 95% purity based on SDS-PAGE and conjugated to HRP. The antibody is produced in goat by using as an immunogen Swine IgG whole molecule |
Goat Swine IgG |
|||
A21090-05ml | Abbkine | 0.5ml | EUR 189.6 |
Description: A polyclonal antibody for detection of Goat Swine IgG from Swine. This Goat Swine IgG antibody is for WB, IHC-P, ELISA. It is Affinity purified using solid phase Swine IgG (H&L) with finally > 95% purity based on SDS-PAGE and conjugated to HRP. The antibody is produced in goat by using as an immunogen Swine IgG whole molecule |
Swine Swine Fever Virus Antibody (CSFV-Ab) ELISA Kit |
|||
abx364798-96tests | Abbexa | 96 tests | EUR 651.6 |
Human Influenza viruses IgG,FLU ELISA Kit |
|||
201-12-1767 | SunredBio | 96 tests | EUR 528 |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
GA-E1783HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
GA-E1783HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human Influenza viruses IgG(FLU)ELISA Kit |
|||
QY-E02255 | Qayee Biotechnology | 96T | EUR 433.2 |
Swine H1N1 Hemagglutinin Antibody |
|||
5233-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. This antibody is specific for the novel swine influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the seasonal H1N1 influenza (A/Brisbane/59/2007 (H1N1)). |
Swine H1N1 Hemagglutinin Antibody |
|||
5233-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. This antibody is specific for the novel swine influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the seasonal H1N1 influenza (A/Brisbane/59/2007 (H1N1)). |
Swine H1N1 Hemagglutinin Peptide |
|||
5233P | ProSci | 0.05 mg | EUR 197.7 |
Description: Swine H1N1 Hemagglutinin peptide |
Swine H1N1 Hemagglutinin Antibody |
|||
5237-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
Swine H1N1 Hemagglutinin Antibody |
|||
5237-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |
Swine H1N1 Hemagglutinin Peptide |
|||
5237P | ProSci | 0.05 mg | EUR 197.7 |
Description: Swine H1N1 Hemagglutinin peptide |
Swine H1N1 Hemagglutinin Antibody |
|||
5241-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. |